A randomized, double-blind, placebo-controlled, multicenter, phase 3 efficacy and safety study of subcutaneous anakinra (Kineret®) in patients with Still’s disease (SJIA and AOSD) followed by an open-label extension
Efficacy, Safety and Tolerability of Tofacitinib for Treatment of Polyarticular Course Juvenile Idiopathic Arthritis (JIA) in Children and Adolescent Subjects
A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF TOFACITINIB FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)
A Project Towards Establishment of a US/Canadian Diagnostic Registry of Children with Chronic Vasculitis (ARCHIVE, A Registry for Children with Vasculitis: e-entry) (Peds Vasculitis)
